These results suggest that TRAIL promotes the interaction of TRAF2 with caspase‐8 to facilitate the polyubiquitination of caspase‐8, leading to TRAIL resistance in gastric cancer cells. The gene discussed is TNFSF10; the disease is gastric cancer.